329 results on '"Yamamoto, Haruko"'
Search Results
2. Early Hyperchloremia is Independently Associated with Death or Disability in Patients with Intracerebral Hemorrhage
3. REsveratrol for VAscular cognitive impairment investigating cerebral Metabolism and Perfusion (REVAMP trial): a study protocol for a randomized, double-blind, placebo-controlled trial
4. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation
5. Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention
6. Abstract WMP2: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial in Acute Non-Cardioembolic Ischemic Stroke With Adrenomedullin
7. Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the Enbalv Trial
8. Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study
9. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort
10. DJS-4 Utilization of clinical research data other than conventional clinical trials for pharmaceuticals and medical devices
11. “BAX602” in Preventing Surgical Adhesion after Extracorporeal Ventricular Assist Device Implantation for Refractory Congestive Heart Failure: Study Protocol for a Multicenter Randomized Clinical Trial
12. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial
13. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data
14. Impact of Renal Impairment on Intensive Blood-Pressure–Lowering Therapy and Outcomes in Intracerebral Hemorrhage: Results From ATACH-2
15. Cigarette Smoking as a Risk Factor for Hematoma Expansion in Primary Intracerebral Hemorrhage: Analysis From a Randomized Clinical Trial
16. Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy
17. Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage
18. Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
19. Sex Differences in Blood Pressure–Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2
20. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
21. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol
22. Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag: A Tripartite Cross-Sectional Survey
23. P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study
24. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study
25. Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
26. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
27. Blood Pressure-Attained Analysis of ATACH 2 Trial
28. Effect of Moderate and Severe Persistent Hyperglycemia on Outcomes in Patients With Intracerebral Hemorrhage
29. sj-pdf-1-wso-10.1177_17474930211044635 - Supplemental material for Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review
30. Cerebral hyperperfusion on arterial spin labeling MRI after reperfusion therapy is related to hemorrhagic transformation
31. Disease duration: the key to accurate CSF tap test in iNPH
32. Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)
33. A Different Case of Penumbra
34. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol
35. Effect of Eicosapentaenoic Acid/ Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Non-Contrast T1-Weighted Imaging: A Randomized Trial
36. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation
37. Network for Clinical Stroke Trials (NeCST) for the Next Stroke Researchers in Japan
38. Invisibility of moving objects: a core symptom of motion blindness
39. Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients
40. Effect of Heart Rate Variabilities on Outcome After Acute Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH‐2
41. Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial
42. sj-pdf-1-wso-10.1177_17474930211035023 - Supplemental material for Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial
43. Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial.
44. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
45. Factors contributing to mortality and morbidity in pregnancy-associated intracerebral hemorrhage in Japan
46. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.
47. Pediatric Medical Devices ― Survey of Pediatric Cardiologists and Cardiovascular Surgeons in Japan ―
48. Abstract P7: Prior Antithrombotic Medication May Affect Outcomes Following Alteplase at 0.6mg for Unknown Onset Stroke: THAWS Randomized Clinical Trial
49. Factors Associated with Early Recanalization Failure following Intravenous rt-PA Therapy for Ischemic Stroke
50. Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: Factors influencing the quantitative results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.